KP-121

Upcoming events – Axsome takes on migraine and Kala looks to dry eye again
EP Vantage
Sun, 11/10/19 - 07:58 pm
Axsome Therapeutics
migraines
AXS-07
Kala Pharmaceuticals
clinical trials
KP-121
dry eye disease
FDA wants additional data on Kala Pharma’s KPI-121
Pharma Letter
Fri, 08/9/19 - 10:43 am
Kala Pharmaceuticals
KP-121
dry eye disease
FDA